SUPERIOR LIMBIC KERATOCONJUNCTIVITIS

SUPERIOR LIMBIC KERATOCONJUNCTIVITIS was reported 8 times

SUPERIOR LIMBIC KERATOCONJUNCTIVITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Semifluorinated Alkane [EPC] 1 0.0004
1 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
2 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
3 Acetylcholine Release Inhibitor [EPC] 1 0.0000
4 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
5 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
6 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000